Financials Kohjin Bio Co., Ltd.

Equities

177A

JP3283630006

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-05-31 EDT 5-day change 1st Jan Change
1,777 JPY +4.28% Intraday chart for Kohjin Bio Co., Ltd. +6.22% -.--%

Valuation

Fiscal Period: March 2025 2026
Capitalization 1 8,912 -
Enterprise Value (EV) 1 8,912 8,912
P/E ratio 14.3 x 13.3 x
Yield 0.79% 0.79%
Capitalization / Revenue 1.89 x 1.74 x
EV / Revenue 1.89 x 1.74 x
EV / EBITDA 7.5 x 6.28 x
EV / FCF -35.1 x -47.2 x
FCF Yield -2.85% -2.12%
Price to Book 1.68 x 1.51 x
Nbr of stocks (in thousands) 5,015 -
Reference price 2 1,777 1,777
Announcement Date - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2024 2025 2026
Net sales 1 4,770 4,717 5,130
EBITDA 1 - 1,188 1,418
EBIT 1 596 799 891
Operating Margin 12.49% 16.94% 17.37%
Earnings before Tax (EBT) 1 635 830 907
Net income 1 384 618 671
Net margin 8.05% 13.1% 13.08%
EPS 2 92.43 124.5 133.7
Free Cash Flow 1 - -254 -189
FCF margin - -5.38% -3.68%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share 2 14.00 14.00 14.00
Announcement Date 24-05-15 - -
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2024 2025 2026
Net Debt - - -
Net Cash position - - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow 1 - -254 -189
ROE (net income / shareholders' equity) 12.1% 14.5% 12%
ROA (Net income/ Total Assets) - - -
Assets 1 - - -
Book Value Per Share 2 803.0 1,056 1,176
Cash Flow per Share 164.0 - -
Capex 1 - 186 1,167
Capex / Sales - 3.94% 22.75%
Announcement Date 24-05-15 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 177A Stock
  4. Financials Kohjin Bio Co., Ltd.